Cargando…
P316: PRIORITIZING PRECISION MEDICINES IN PEDIATRIC BLOOD CANCER: EXPERIENCE OF THE DUTCH INDIVIDUALIZED THERAPY (ITHER) STUDY’S MOLECULAR TUMOR BOARD
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428480/ http://dx.doi.org/10.1097/01.HS9.0000968176.08568.30 |
| _version_ | 1785090480238755840 |
|---|---|
| author | Boer, Judith M. Ilan, Uri Hoen, Babette D.J. Boeree, Aurelie Langenberg, Karin P.S. Koster, Jan Bourquin, Jean-Pierre Molenaar, Jan J. Goemans, Bianca den Boer, Monique L. Zwaan, Michel |
| author_facet | Boer, Judith M. Ilan, Uri Hoen, Babette D.J. Boeree, Aurelie Langenberg, Karin P.S. Koster, Jan Bourquin, Jean-Pierre Molenaar, Jan J. Goemans, Bianca den Boer, Monique L. Zwaan, Michel |
| author_sort | Boer, Judith M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428480 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284802023-08-17 P316: PRIORITIZING PRECISION MEDICINES IN PEDIATRIC BLOOD CANCER: EXPERIENCE OF THE DUTCH INDIVIDUALIZED THERAPY (ITHER) STUDY’S MOLECULAR TUMOR BOARD Boer, Judith M. Ilan, Uri Hoen, Babette D.J. Boeree, Aurelie Langenberg, Karin P.S. Koster, Jan Bourquin, Jean-Pierre Molenaar, Jan J. Goemans, Bianca den Boer, Monique L. Zwaan, Michel Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428480/ http://dx.doi.org/10.1097/01.HS9.0000968176.08568.30 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Boer, Judith M. Ilan, Uri Hoen, Babette D.J. Boeree, Aurelie Langenberg, Karin P.S. Koster, Jan Bourquin, Jean-Pierre Molenaar, Jan J. Goemans, Bianca den Boer, Monique L. Zwaan, Michel P316: PRIORITIZING PRECISION MEDICINES IN PEDIATRIC BLOOD CANCER: EXPERIENCE OF THE DUTCH INDIVIDUALIZED THERAPY (ITHER) STUDY’S MOLECULAR TUMOR BOARD |
| title | P316: PRIORITIZING PRECISION MEDICINES IN PEDIATRIC BLOOD CANCER: EXPERIENCE OF THE DUTCH INDIVIDUALIZED THERAPY (ITHER) STUDY’S MOLECULAR TUMOR BOARD |
| title_full | P316: PRIORITIZING PRECISION MEDICINES IN PEDIATRIC BLOOD CANCER: EXPERIENCE OF THE DUTCH INDIVIDUALIZED THERAPY (ITHER) STUDY’S MOLECULAR TUMOR BOARD |
| title_fullStr | P316: PRIORITIZING PRECISION MEDICINES IN PEDIATRIC BLOOD CANCER: EXPERIENCE OF THE DUTCH INDIVIDUALIZED THERAPY (ITHER) STUDY’S MOLECULAR TUMOR BOARD |
| title_full_unstemmed | P316: PRIORITIZING PRECISION MEDICINES IN PEDIATRIC BLOOD CANCER: EXPERIENCE OF THE DUTCH INDIVIDUALIZED THERAPY (ITHER) STUDY’S MOLECULAR TUMOR BOARD |
| title_short | P316: PRIORITIZING PRECISION MEDICINES IN PEDIATRIC BLOOD CANCER: EXPERIENCE OF THE DUTCH INDIVIDUALIZED THERAPY (ITHER) STUDY’S MOLECULAR TUMOR BOARD |
| title_sort | p316: prioritizing precision medicines in pediatric blood cancer: experience of the dutch individualized therapy (ither) study’s molecular tumor board |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428480/ http://dx.doi.org/10.1097/01.HS9.0000968176.08568.30 |
| work_keys_str_mv | AT boerjudithm p316prioritizingprecisionmedicinesinpediatricbloodcancerexperienceofthedutchindividualizedtherapyitherstudysmoleculartumorboard AT ilanuri p316prioritizingprecisionmedicinesinpediatricbloodcancerexperienceofthedutchindividualizedtherapyitherstudysmoleculartumorboard AT hoenbabettedj p316prioritizingprecisionmedicinesinpediatricbloodcancerexperienceofthedutchindividualizedtherapyitherstudysmoleculartumorboard AT boereeaurelie p316prioritizingprecisionmedicinesinpediatricbloodcancerexperienceofthedutchindividualizedtherapyitherstudysmoleculartumorboard AT langenbergkarinps p316prioritizingprecisionmedicinesinpediatricbloodcancerexperienceofthedutchindividualizedtherapyitherstudysmoleculartumorboard AT kosterjan p316prioritizingprecisionmedicinesinpediatricbloodcancerexperienceofthedutchindividualizedtherapyitherstudysmoleculartumorboard AT bourquinjeanpierre p316prioritizingprecisionmedicinesinpediatricbloodcancerexperienceofthedutchindividualizedtherapyitherstudysmoleculartumorboard AT molenaarjanj p316prioritizingprecisionmedicinesinpediatricbloodcancerexperienceofthedutchindividualizedtherapyitherstudysmoleculartumorboard AT goemansbianca p316prioritizingprecisionmedicinesinpediatricbloodcancerexperienceofthedutchindividualizedtherapyitherstudysmoleculartumorboard AT denboermoniquel p316prioritizingprecisionmedicinesinpediatricbloodcancerexperienceofthedutchindividualizedtherapyitherstudysmoleculartumorboard AT zwaanmichel p316prioritizingprecisionmedicinesinpediatricbloodcancerexperienceofthedutchindividualizedtherapyitherstudysmoleculartumorboard |